Medicare covers low-dose CT lung-cancer screening

The day a scan became a benefit

In February 2015, Medicare started paying for yearly lung cancer screening. The test is a low-dose CT scan of the chest. A CT scan uses X-rays to build a detailed picture of the lungs. Low-dose means it uses far less radiation than a standard chest CT.

The first rule was narrow. A person had to be 55 to 77 years old. They had to have no signs of lung cancer. They had to have smoked at least 30 pack-years. One pack-year means one pack a day for one year. They also had to smoke now, or have quit within the past 15 years.

Medicare asked for more than a scan order. A doctor or other qualified practitioner had to write the order. Before the first scan, the person had to attend a counseling and shared decision-making visit. That visit covers who gains from screening, what can go wrong, and help with quitting smoking. Imaging centers had to meet a radiation dose limit, report nodules in a standard way, and send data on every scan to a registry.

The trial behind the decision

The rule rested on the National Lung Screening Trial, run by the National Cancer Institute. It enrolled 53,454 people aged 55 to 74 who had smoked at least 30 pack-years. Half had three yearly low-dose CT scans. Half had three yearly chest X-rays.

People in the CT group had a 15 to 20 percent lower risk of dying of lung cancer. Put another way, that was about three fewer deaths for every 1,000 people screened, over roughly seven years of follow-up. That is a real gain, and it is also a modest one. It describes a group, not any single person.

The rules are wider now

Medicare revisited the question and issued a new decision in 2022. The age band now starts at 50 and still ends at 77. The smoking history needed dropped to 20 pack-years. The 15-year quit rule stayed. The counseling visit and the written order stayed too.

The U.S. Preventive Services Task Force, an independent panel of experts, goes a little further. It advises yearly low-dose CT for adults aged 50 to 80 with a 20 pack-year history who smoke now or quit within 15 years. Coverage rules change, so check the current rules rather than a page like this one. If you want the wider background first, our guide to lung cancer covers the disease itself.

What the scan usually finds

Most of what a chest CT picks up is not cancer. It finds nodules, which are small round spots in lung tissue. Many are old scars or healed infections. In the trial, 24.2 percent of low-dose CT screens were called positive. The large majority of those were false alarms.

A spot on a first scan does not mean surgery. Small nodules are often watched with a repeat scan in a few months. Larger or odd-looking ones may lead to a PET scan or a biopsy, in which a small piece of tissue is taken and checked under a microscope.

The costs on the other side of the ledger

NCI lists three harms plainly. Screening produces false-positive results, which can lead to tests and procedures that were never needed. It causes some overdiagnosis, meaning it finds cancers that would never have caused symptoms. And the scans add radiation exposure over the years. Our page on the benefits and harms of screening walks through how to weigh those against each other.

Why the timing matters so much

Lung cancer is usually found late. In SEER data from the National Cancer Institute, 51 percent of cases are already distant, meaning the cancer has spread to other organs, by the time it is diagnosed. Only 24 percent are still confined to the lung.

That gap shows in the numbers. Five-year relative survival is 65.5 percent for localized disease, 38.2 percent for regional disease, and 10.5 percent when the cancer is distant. Across all stages it is 29.5 percent. These are group averages from people diagnosed between 2016 and 2022. They are not a forecast for one person, and they lag behind newer treatments.

When to ask about a scan

Bring it up at a check-up if all of these fit you:

• you are between 50 and 77 years old, or up to 80 under the Task Force advice
• you have at least 20 pack-years of smoking history
• you smoke now, or you quit within the past 15 years
• you have no symptoms of lung cancer right now

Screening is for people who feel well. Symptoms call for a different path. NCI lists a cough that does not go away or gets worse, chest pain, trouble breathing, wheezing, blood in sputum, hoarseness, trouble swallowing, weight loss with no known cause, and swelling in the face or neck veins. Any of these needs an appointment now, whatever your smoking history. Screening rules do not apply once symptoms are present.

What this does and doesn't change

• Coverage criteria have already changed once. Check the current rules with Medicare or your plan, not from a summary.
• The 15 to 20 percent figure came from one trial in a high-risk group. It is not a promise of benefit for any individual.
• A clear scan is not a clean bill of health for good. Screening is annual for a reason.
• Screening does not replace quitting. Stopping smoking lowers risk in a way no scan can.

Sources

• CMS decision memo, screening for lung cancer with LDCT (CAG-00439N, 2015)
• CMS final decision memo (CAG-00439R, 2022)
• NCI: National Lung Screening Trial
• NCI: Lung Cancer Screening (PDQ) — Patient Version
• NCI: Non-Small Cell Lung Cancer Treatment (PDQ) — Patient Version
• SEER Cancer Stat Facts: Lung and Bronchus Cancer
• USPSTF: Lung Cancer Screening recommendation

How this page was made

An AI-assisted editorial system helped prepare this page. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown. Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.

Found an error, a broken source link, outdated information, or wording that feels insensitive? Report it here — we log and act on material corrections.